All type of patients: 7 trials - IMpower150 (Teff) - IMpower150 (WT) - OAK - POPLAR Phase 2 atezolizumab - GO29432 - IMpower 110 - IMpower 131
First line: 6 trials - IMpower150 (Teff) - IMpower150 (WT) - GO29432 - IMpower 110 - IMpower 132 - IMpower 133
Second line : 4 trials - OAK - POPLAR Phase 2 atezolizumab - IMpower 010 - IMpower 210
5 trials - IMVIGOR-130 (monotherapy) - IMVIGOR-130 combination - IMvigor010 - IMvigor210 - IMvigor211 (IC2/3)